Detection of antibiotic resistance in vitro

被引:8
作者
Greenwood, D [1 ]
机构
[1] Univ Nottingham Hosp, Queens Med Ctr, Div Microbiol & Infect Dis, Sch Clin Lab Sci, Nottingham NG7 2UH, England
关键词
antibiotics; antimicrobial agents; sensitivity testing; resistance; surveillance;
D O I
10.1016/S0924-8579(00)00141-2
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Testing the susceptibility of bacteria to antimicrobial agents is fundamental to the study of resistance. The qualitative methods that were originally devised evolved separately in different countries and as the need for more precise quantitative information became clear, different solutions to the problem emerged. Consequently. the methods now recommended vary widely between countries acid achieving a consensus on standardisation has proved difficult. Sensitivity testing serves two purposes to provide meaningful results to the prescriber and to monitor changes in susceptibility of microbial populations. The diagnostic purpose is adequately served by the diversity of methods used, provided they are performed and controlled efficiently. Highly standardised methods are however needed for surveillance in the national and international context and to provide meaningful comparisons to be made between individual centres. These needs are best met by the use of agreed methods and interpretative criteria in sentinel laboratories. No sensitivity test method can provide the 'correct' answer all the time, if only because the 'correct' answer in therapeutic terms is wt known with ally certainty. Laboratories providing a sensitivity testing service can influence prescribing and hence the development of resistance - in a number of different ways and the quest for standardisation at all costs should not obscure these important functions. (C) 2000 Elsevier Science B.V. and International Society of Chemotherapy. All rights reserved.
引用
收藏
页码:303 / 306
页数:4
相关论文
共 9 条
  • [1] Abraham EP, 1941, LANCET, V2, P177
  • [2] BARBER M, 1966, 55 ASS CLIN PATH
  • [3] BAUER AW, 1966, AM J CLIN PATHOL, V45, P493
  • [4] Ericsson H.M., 1971, ACTA PATHOL MICR B S, P217
  • [5] Fleming A, 1929, BRIT J EXP PATHOL, V10, P226
  • [6] Greenwood D, 1997, J CHEMOTHERAPY, V9, P7
  • [7] Surveillance of antimicrobial resistance
    Livermore, DM
    Macgowan, AP
    Wale, MCJ
    [J]. BRITISH MEDICAL JOURNAL, 1998, 317 (7159) : 614 - 615
  • [8] The global epidemic nature of antimicrobial resistance and the need to monitor and manage it locally
    OBrien, TF
    [J]. CLINICAL INFECTIOUS DISEASES, 1997, 24 : S2 - S8
  • [9] *WHO, 1961, WHO TECHN REP SER, V201, P1